Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

BIZARRE: Is merck stock outperforming the dow - What They Never Told You

Valued at a market cap of $207.8 billion, Merck & Co., Inc. (MRK) is a leading healthcare company based in Rahway, New Jersey. It develops and markets human health pharmaceuticals across key therapeutic areas like oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes. Additionally, it offers veterinary medicines, vaccines, and health management solutions and services for both livestock and companion animals.

Companies worth $200 billion or more are typically classified as “mega-cap stocks,” and MRK fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the drug manufacturers - general industry. The company’s strength lies in its strong research and development (R&D) capabilities, which fuel its leadership in innovative medicines and vaccines. The combination of cutting-edge innovation, a robust product pipeline, and global market presence positions Merck as a key player in advancing healthcare worldwide.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.